Compositions and methods for growth factor modulation
US-12577296-B2 · Mar 17, 2026 · US
This page is not indexed by search engines while we improve data quality.
Schurpf Thomas patents
Schurpf Thomas is listed as an inventor on 56 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Schurpf Thomas |
| Total patents | 56 |
| First publication | Nov 26, 2015 |
| Latest publication | Mar 17, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Compositions and methods for growth factor modulation
US-12454570-B2 · Oct 28, 2025 · US
HIGH-AFFINITY, ISOFORM-SELECTIVE TGFß1 INHIBITORS AND USE THEREOF
US-2025257125-A1 · Aug 14, 2025 · US
LTBP complex-specific inhibitors of TGF-beta 1 and uses thereof
US-12358992-B2 · Jul 15, 2025 · US
Isoform-selective tgfb1 inhibitors and use thereof
US-2025215072-A1 · Jul 3, 2025 · US
LTBP COMPLEX-SPECIFIC INHIBITORS OF TGFb AND USES THEREOF
US-2025179164-A1 · Jun 5, 2025 · US
TGFβ antibodies, methods and uses
US-12281159-B2 · Apr 22, 2025 · US
Methods of screening for high-affinity, isoform-selective TGFβ1 inhibitors
US-12252531-B2 · Mar 18, 2025 · US
LTBP complex-specific inhibitors of TGFβ and uses thereof
US-12173059-B2 · Dec 24, 2024 · US
Compositions and methods for growth factor modulation
US-2024368261-A1 · Nov 7, 2024 · US
Recent patents
Latest publications not already listed above.
Isoform-selective TGFB1 inhibitors and use thereof
US-12122823-B2 · Oct 22, 2024 · US
LTBP COMPLEX-SPECIFIC INHIBITORS OF TGFb1 AND USES THEREOF
US-2024301073-A1 · Sep 12, 2024 · US
Tgf-beta inhibitors and therapeutic use thereof
US-2024294623-A1 · Sep 5, 2024 · US
Isoform-specific, context-permissive tgfb1 inhibitors and use thereof
US-2024016928-A1 · Jan 18, 2024 · US
Compositions and methods for growth factor modulation
US-11827698-B2 · Nov 28, 2023 · US
TGFbeta1-BINDING IMMUNOGLOBULINS AND USE THEREOF
US-2023348583-A1 · Nov 2, 2023 · US
TGFβ1-binding immunoglobulins and use thereof
US-11643459-B2 · May 9, 2023 · US
Tgfb inhibitors and use thereof
US-2023057012-A1 · Feb 23, 2023 · US
Tgf-beta inhibitors and use thereof
US-2023050148-A1 · Feb 16, 2023 · US
LTBP COMPLEX-SPECIFIC INHIBITORS OF TGFb AND USES THEREOF
US-2022363741-A1 · Nov 17, 2022 · US
LTBP complex-specific inhibitors of TGFβ and uses thereof
US-11365245-B2 · Jun 21, 2022 · US
LTBP COMPLEX-SPECIFIC INHIBITORS OF TGFb AND USES THEREOF
US-2022064276-A1 · Mar 3, 2022 · US
Isoform-selective tgfb1 inhibitors and use thereof
US-2022064275-A1 · Mar 3, 2022 · US
LTBP complex-specific inhibitors of TGFβ and uses thereof
US-11214614-B2 · Jan 4, 2022 · US
TGFß1 INHIBITORS AND USE THEREOF
US-2021340238-A1 · Nov 4, 2021 · US
Isoform-selective TGFβ1 inhibitors and use thereof
US-11130803-B2 · Sep 28, 2021 · US
Compositions and methods for growth factor modulation
US-2021284722-A1 · Sep 16, 2021 · US
TGFBeta Antibodies, Methods and Uses
US-2021277100-A1 · Sep 9, 2021 · US
HIGH-AFFINITY, ISOFORM-SELECTIVE TGFß1 INHIBITORS AND USE THEREOF
US-2021122814-A1 · Apr 29, 2021 · US
Compositions and methods for growth factor modulation
US-10981981-B2 · Apr 20, 2021 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Scholar Rock Inc | 56 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07K16/22 | 56 |
| C07K2317/92 | 52 |
| C07K2317/76 | 47 |
| A61P35/00 | 45 |
| A61P13/12 | 41 |